Omega Healthcare Investors (NYSE:OHI) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Wednesday.
According to Zacks, “Omega Healthcare Investors, Inc. was incorporated in the State of Maryland. It is a self-administered real estate investment trust (REIT), investing in income producing healthcare facilities, principally long-term care facilities located in the United States (U.S.) and the United Kingdom (U.K.). The Company provide lease or mortgage financing to qualified operators of skilled nursing facilities (SNFs) and, to a lesser extent, assisted living facilities (ALFs), independent living facilities and rehabilitation and acute care facilities. It has historically financed investments through borrowings under its revolving credit facilities, private placements or public offerings of its debt and equity securities, the assumption of secured indebtedness, retention of cash flow, or a combination of these methods. “
OHI has been the subject of several other reports. ValuEngine upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a report on Monday, August 13th. Cantor Fitzgerald reissued a “buy” rating and issued a $34.00 target price on shares of Omega Healthcare Investors in a research report on Monday, August 6th. Stifel Nicolaus raised their target price on Omega Healthcare Investors from $27.00 to $30.00 and gave the stock a “hold” rating in a research report on Tuesday, August 7th. Mitsubishi UFJ Financial Group reissued a “neutral” rating on shares of Omega Healthcare Investors in a research report on Tuesday, October 2nd. Finally, MED initiated coverage on Omega Healthcare Investors in a research report on Tuesday, October 2nd. They issued a “neutral” rating and a $31.00 target price on the stock. They noted that the move was a valuation call. Nine equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Omega Healthcare Investors presently has a consensus rating of “Hold” and an average target price of $30.00.
NYSE OHI traded down $1.06 during trading hours on Wednesday, hitting $32.49. The company’s stock had a trading volume of 105,056 shares, compared to its average volume of 1,774,325. Omega Healthcare Investors has a 12 month low of $24.90 and a 12 month high of $33.77. The company has a market capitalization of $6.68 billion, a price-to-earnings ratio of 9.82, a PEG ratio of 5.61 and a beta of 0.29. The company has a debt-to-equity ratio of 1.15, a quick ratio of 4.03 and a current ratio of 4.03.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Friday, August 3rd. The real estate investment trust reported $0.75 EPS for the quarter, topping the consensus estimate of $0.73 by $0.02. Omega Healthcare Investors had a return on equity of 2.49% and a net margin of 10.61%. The company had revenue of $192.85 million during the quarter, compared to the consensus estimate of $200.30 million. During the same period last year, the company earned $0.87 EPS. Omega Healthcare Investors’s revenue for the quarter was down .6% on a year-over-year basis. On average, equities analysts predict that Omega Healthcare Investors will post 2.97 earnings per share for the current fiscal year.
Large investors have recently made changes to their positions in the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Omega Healthcare Investors by 179.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 53,009 shares of the real estate investment trust’s stock worth $1,643,000 after purchasing an additional 34,068 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Omega Healthcare Investors by 14.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,689,457 shares of the real estate investment trust’s stock valued at $176,373,000 after buying an additional 736,393 shares in the last quarter. Macquarie Group Ltd. lifted its position in shares of Omega Healthcare Investors by 210.0% during the 2nd quarter. Macquarie Group Ltd. now owns 295,023 shares of the real estate investment trust’s stock valued at $9,146,000 after buying an additional 199,848 shares in the last quarter. Green Street Investors LLC purchased a new position in shares of Omega Healthcare Investors during the 3rd quarter valued at about $5,224,000. Finally, Schwab Charles Investment Management Inc. lifted its position in shares of Omega Healthcare Investors by 10.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 984,363 shares of the real estate investment trust’s stock valued at $30,516,000 after buying an additional 91,566 shares in the last quarter. 72.39% of the stock is currently owned by institutional investors and hedge funds.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Story: Stock Symbol
Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.